Repositioning serotonergic antagonists as therapeutic agents in gastric cancer: induction of apoptosis, inhibition of cell migration, and cell cycle arrest in AGS cells
- 29 December 2025
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 78 (1) , 22
Abstract
Drug repurposing in oncology can reduce the time and cost of new drug development. Studies suggest that depression influences tumor progression, and some antidepressants exhibit anti-tumor effects. This study evaluated the effects of serotonergic antagonists—tropisetron, imipramine, ketanserin, and cyproheptadine—on AGS gastric cancer cells. The half-maximal inhibitory concentration (IC50) values of drugs were determined after 48 h in AGS cells using the MTT assay. Cell cycle distribution and apoptosis were evaluated by flow cytometry. Morphological changes were observed by Acridine Orange/Ethidium Bromide staining. The wound-healing assay was used to assess the effects of the drugs on cell migration. Real-time PCR was used to measure the expression of 5-hydroxytryptamine (5-HT) receptors (5-HT2A, 5-HT2B, 5-HT3A), serotonin transporter (SLC6A4/SERT), apoptosis-related genes (Bcl-2, Bax), and proliferating cell nuclear antigen (PCNA). All drugs significantly inhibited the growth of AGS cell in vitro. All four drugs induced apoptosis and inhibited cell migration with varying efficacies. Imipramine induced G1/S phase arrest, whereas tropisetron, ketanserin, and cyproheptadine increased the sub-G1 cell population. Gene expression analysis revealed decreased Bcl-2 and PCNA levels and increased Bax expression.These findings suggest the potential of tropisetron, imipramine, ketanserin, and cyproheptadine as repurposed therapeutic agents for gastric cancer.Keywords
This publication has 42 references indexed in Scilit:
- Repurposing serotonergic drugs for gastric cancer: induction of apoptosis in vitroMolecular Biology Reports, 2025
- Dissecting the novel abilities of aripiprazole: The generation of anti-colorectal cancer effects by targeting Gαq via HTR2BActa Pharmaceutica Sinica B, 2023
- Knockdown and inhibition of hydroxytryptamine receptor 1D suppress proliferation and migration of gastric cancer cellsBiochemical and Biophysical Research Communications, 2022
- Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB downregulationCell Biology and Toxicology, 2021
- Nervous system and gastric cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Antipsychotic use is inversely associated with gastric cancer risk: A nationwide population‐based nested case‐control studyCancer Medicine, 2019
- Serotonin and human cancer: A critical viewBiochimie, 2019
- Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonistsBiochemical Pharmacology, 2017
- Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathwaysCancer Letters, 2016
- Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell linesCancer, 2009